Last CNY17.20 CNY
Change Today -0.32 / -1.83%
Volume 11.5M
As of 2:05 AM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

zhejiang hisun pharmaceuti-a (600267) Snapshot

Open
CNY17.49
Previous Close
CNY17.52
Day High
CNY17.59
Day Low
CNY17.06
52 Week High
12/15/14 - CNY18.95
52 Week Low
05/19/14 - CNY13.53
Market Cap
16.6B
Average Volume 10 Days
14.1M
EPS TTM
CNY0.37
Shares Outstanding
965.5M
EX-Date
06/25/14
P/E TM
46.1x
Dividend
CNY0.11
Dividend Yield
0.64%
Current Stock Chart for ZHEJIANG HISUN PHARMACEUTI-A (600267)

Related News

No related news articles were found.

zhejiang hisun pharmaceuti-a (600267) Related Businessweek News

No Related Businessweek News Found

zhejiang hisun pharmaceuti-a (600267) Details

Zhejiang Hisun Pharmaceutical Co. Ltd. provides various pharmaceutical products and services to patients and its business partners. The company provides antineoplastic, cardiovascular, anti-infection, endocrine control, anti-parasite, anti-tumor, anti-infective, and anti-immunosuppressive drugs, as well as animal remedies and muscle and skeletal system products. It also provides APIs and finished drugs, and medical information and product consulting services. The company markets and distributes its products under the HISUN brand in approximately 70 regions and countries. It has collaboration with Ambrx Inc. to develop and commercialize bispecifics for cancer. The company was founded in 1956 and is headquartered in Taizhou, China.

Founded in 1956

zhejiang hisun pharmaceuti-a (600267) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

zhejiang hisun pharmaceuti-a (600267) Key Developments

Zhejiang Hisun Pharmaceutical Co., Ltd., Board Meeting, Dec 12, 2014

Zhejiang Hisun Pharmaceutical Co., Ltd., Board Meeting, Dec 12, 2014. Agenda: To approve the proposal of providing financial aid for its holding subsidiary; and to consider the proposal of using some idle raised funds to temporarily supplement current capital.

Zhejiang Hisun Pharmaceutical Co., Ltd. Announces Earnings Results for the First Three Quarters of 2014

Zhejiang Hisun Pharmaceutical Co., Ltd. announced earnings results for the first three quarters of 2014. For the period, the company reported basic earning per share of CNY 0.270 and weighted average return on net assets of 4.560%.

Zhejiang Hisun Pharmaceutical Co., Ltd., Board Meeting, Oct 24, 2014

Zhejiang Hisun Pharmaceutical Co., Ltd., Board Meeting, Oct 24, 2014. Agenda: To consider third quarter report of 2014; to consider the proposal of using some idle raised funds to temporarily supplement current capital; and to consider the proposal of change of accounting policy and adjustment to financial information.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600267:CH CNY17.20 CNY -0.32

600267 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600267.
View Industry Companies
 

Industry Analysis

600267

Industry Average

Valuation 600267 Industry Range
Price/Earnings 45.2x
Price/Sales 1.5x
Price/Book 2.3x
Price/Cash Flow 51.9x
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZHEJIANG HISUN PHARMACEUTI-A, please visit www.hisunpharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.